PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Nat Mater. Author manuscript; available in PMC 2011 December 13.
Published in final edited form as:
Published online 2010 December 5. doi:  10.1038/nmat2903
PMCID: PMC3236662
NIHMSID: NIHMS268172

Mechanics and contraction dynamics of single platelets and implications for clot stiffening

Abstract

Platelets interact with fibrin polymers to form blood clots at sites of vascular injury13. Bulk studies have shown clots to be active materials, with platelet contraction driving the retraction and stiffening of clots4. However, neither the dynamics of single-platelet contraction nor the strength and elasticity of individual platelets, both of which are important for understanding clot material properties, have been directly measured. Here we use atomic force microscopy to measure the mechanics and dynamics of single platelets. We find that platelets contract nearly instantaneously when activated by contact with fibrinogen and complete contraction within 15 min. Individual platelets can generate an average maximum contractile force of 29 nN and form adhesions stronger than 70 nN. Our measurements show that when exposed to stiffer microenvironments, platelets generated higher stall forces, which indicates that platelets may be able to contract heterogeneous clots more uniformly. The high elasticity of individual platelets, measured to be 10 kPa after contraction, combined with their high contractile forces, indicates that clots may be stiffened through direct reinforcement by platelets as well as by strain stiffening of fibrin under tension due to platelet contraction. These results show how the mechanosensitivity and mechanics of single cells can be used to dynamically alter the material properties of physiologic systems.

At sites of vascular injury, platelets and fibrin polymers interact to form blood clots that prevent haemorrhage. During clot formation, platelets bind to the fibrin network and aggregate. Actomyosin-based contraction of individual platelets then leads to substantial decreases in clot size and exerts significant strains on fibrin scaffolds2, altering clot organization and stiffness. Indeed, the addition of platelets increases the elastic moduli of fibrin gels by approximately tenfold, according to bulk studies of isometrically contracting clots4,5. As clots are exposed to a wide range of external forces in a haemodynamic environment, clot mechanical properties affect numerous aspects of haemostasis and thrombosis6, and recent clinical studies have correlated altered clot mechanics with disease states. For example, clots in young heart attack patients are much stiffer and resistant to degradation than in healthy subjects7. Conversely, clots in patients with bleeding disorders such as haemophilia are much softer and prone to degradation than in healthy subjects8. Interest in the factors that control clot mechanics has therefore focused attention on the role of platelets and fibrin.

Assays developed over the past few decades have provided measurements of the total contraction force exerted during clot retraction and of the mechanical properties of fibrin gels with and without platelets, but only at the bulk clot level4,9. As platelets drive clot contraction, single-cell measurements are required to obtain a mechanistic understanding of the retraction process and to identify specific therapeutic targets for disease states in which platelet/clot retraction is pathologically altered. However, the complexity of clots makes isolation and investigation of individual platelet and fibrin polymer behaviour difficult. Recent in vitro studies have provided new insight into the mechanical properties of fibrin polymers10,11, particularly the high extensibility of fibrin. Less is known about single-platelet mechanics, owing in part to platelets’ small size and their propensity to rapidly activate, adhere, and spread onto flat surfaces12. The elastic modulus of a contracted platelet remains unknown, and basic biophysical characteristics of individual contracting platelets, such as timescale, maximum contraction forces, and adhesion strength, have not been measured.

To measure the contraction, mechanics and dynamics of single platelets, we used a custom-built atomic force microscope (AFM) with an integrated ‘side-view’ fluorescence microscope13. Fluorescently labelled single platelets suspended in a buffer solution were positioned between a fibrinogen-coated cantilever and a fibrinogen-coated surface, emulating the geometry of a platelet within a fibrin gel containing pore sizes from 1 to 5 μm (Fig. 1a; ref. 12). Confocal microscopy showed that as a platelet spreads between two opposing fibrinogen-coated surfaces, actin structures are formed between those surfaces (Fig. 1b, Supplementary Fig. S1) and enable the platelet to contract (see the Methods section).

Figure 1
Measuring the contraction of single platelets with AFM

To prevent further bleeding, clots must form efficiently and promptly; therefore, all platelet processes, especially contraction, must occur rapidly. Using AFM to monitor platelet contractile force and dynamics, we found that activated single platelets began contracting nearly instantaneously on contact with the fibrinogen-coated cantilever and surface. In a typical experiment, the platelet reached a maximum rate of contraction 2–3 min after contact and then stalled after 10–15 min as it exerted a maximum contraction force of 15 nN (Fig. 1c–e, Supplementary Video S1). After the platelet reached maximum contraction, it was able to sustain that tension for many minutes until the end of the experiment (Fig. 1c). This rapid timescale of platelet contraction was seen in all experiments (Supplementary Fig. S2), even when an external load was applied (Supplementary Information). Interestingly, the timescale we observed is consistent with the minimum reported time for platelet-induced bulk clot retraction of 15 min, although retraction times up to 120 min have been reported1416. This broad range of clot retraction timescales may be due to differences in the concentration and/or organization of the fibrin, platelet concentrations, or platelet activation at different time points within the clot in those systems.

Clot structure can be anisotropic and spatially non-uniform12, leading to a heterogeneity of mechanical microenvironments platelets might encounter. As fibrinogen density correlates with clot stiffness17, we investigated whether platelet contraction force and the rate of increase in contraction force (nN s−1) are influenced by alterations in the stiffness of their surroundings. To conduct these experiments, we used cantilevers with different stiffnesses (either ~18 or ~43 pN nm−1), which correlate with physiologically relevant mechanical properties of fibrin clots (~12 or ~29 kPa, respectively; see Supplementary Information)17. To measure the maximum contraction force of an individual platelet, we also used a feedback algorithm that places the platelet under isometric contraction, also known as a distance or isometric clamp18, which is equivalent to an infinitely stiff microenvironment (Fig. 2a,b, Supplementary Video S2). This feedback algorithm modulates the position of the surface during platelet contraction such that the distance between the cantilever and surface is held constant.

Figure 2
Stiffness dependence and timescale of platelet contraction

Under these three different microenvironmental stiffness conditions, we found that platelet contraction was significantly altered. As cantilever stiffness increased, platelets exhibited higher contraction forces and rates, and generated more work (Fig. 2c,d and Supplementary Fig. S3). Interestingly, a ~2.5-fold increase in cantilever stiffness led to a nearly 2-fold increase in the median platelet maximum contraction force, so that actual contraction distances were similar. However, this relationship may be different at lower stiffness values. Despite the relative simplicity of platelets, such stiffness-dependent behaviour is similar to that reported for other contractile cells, which pull to a constant fraction of their original height over a certain regime of stiffness.1921. Physiologically, the ability of platelets to pull with higher forces in stiffer microenvironments, such as areas of high fibrin density, would be expected to lead to a more uniform contraction of a heterogeneous fibrin gel in a blood clot. Stiffness in a fibrin gel has been shown to scale with the 1.67 power of fibrin concentration17. Thus, we estimate that a given platelet will contract with 2.5 times as much force for an increase in fibrin concentration by a factor of 2, and generate 2 times as much work (Supplementary Information). Further studies are needed to correlate contraction force and local fibrin elasticity in clots.

Our experiments reveal that platelets exert remarkably high contraction forces, with the magnitude of maximum contraction forces ranging from 1.5 to 79 nN (mean: 19 ± 3.1 nN, n = 30, s.e.m.; Fig. 2c). This roughly matches with the prediction of a previous study of bulk clot retraction in which the contraction force of a single platelet was extrapolated to be 20 nN (ref. 22), although the prediction does not capture the large variation in contraction forces or stiffness dependence of platelet contraction that we measure. The forces exerted by individual platelets are remarkable given their small size. Although single myoblast cells have been shown to exert up to 300 nN (ref. 19), they are approximately three orders of magnitude larger in volume than platelets23. Thus, platelets exert a force per volume two orders of magnitude greater than that exerted by myoblasts, or a force per area that is one order of magnitude greater. As single myosin II molecules can generate a maximum of ~6 pN of force24,25 and there are approximately 12,000 myosin II molecules in each platelet2, we estimate the maximum theoretical contractional force of a single platelet to be 72 nN. In our isometric clamp conditions, we measured a median contraction force of 18 nN, which is ~25% of this maximum value. Interestingly, skeletal muscle cells, with highly ordered sarcomere contractile units, also exert maximum contractile forces with 30% of the myosins contracting, although skeletal muscle cells contain muscle myosin II as opposed to the non-muscle myosin II in platelets25. Thus, the contraction forces generated by platelets, without any prior ordering of contractile actomyosin fibres, are surprisingly high.

The large forces exerted by platelets also have implications for the interaction between platelets and fibrin. Protofibrils of fibrin are estimated to unfold at a force of ~75 pN (refs 11,26). Although these protofibrils are linked together into fibres, the large forces exerted by platelets may still be high enough to cause unfolding of some fibrin polymers, potentially leading to permanent alteration of the fibre structure11.

After clot formation and retraction, preservation of clot mechanical integrity is vital to maintaining haemostasis, and contracted platelets have been shown in bulk studies to enhance clot stiffness4,27. To understand how, we investigated the mechanical properties of single contracted platelets. After platelet contraction was completed, we measured the elasticity and extensibility of single platelets, as well as the adhesion strength between the platelet and the fibrinogen-coated surface or cantilever (Fig. 3a–b, Methods, Supplementary Video S3). We found the elasticity of a contracted platelet in this regime to have a mean of 9.85 ± 1.71 kPa (n = 12, s.e.m.). The adhesion force of the platelet, measured when the platelet detached from the surface or cantilever (Fig. 3a), had a mean of 69.0 ± 12.7 nN (n = 11, s.e.m.), corresponding to rupture stresses of approximately 5 kPa. Although this measurement represents a minimum, as rupture could have occurred between the platelet and the fibrinogen or between the fibrinogen and the surface, platelet adhesion force per area is at least 600 times higher than that measured between single leukocytes and endothelial cells13,28. We also found the extensibility of the platelet to have a mean of 1.57 ± 0.22 (n = 11, s.e.m.) before rupture. Interestingly, both platelet elasticity and adhesion strength correlated with maximum contraction force (r = 0.76 and 0.77, respectively, P < 0.05), indicating that the more force a platelet exerts, the stiffer and more adhesive it becomes.

Figure 3
Elasticity and adhesion measurement for contracted platelets

Previous work has shown that the elasticity of platelet-rich clots (~600 Pa) is 10-fold greater than platelet-free clots (~70 Pa) in an isometric system in which clot length is held constant4,9. Platelets are exerting high contractile forces on the fibrin, so that the strain stiffening of individual fibrin fibres under tension would lead to an increase in overall network elasticity, similar to stiffening of actin networks due to tensional forces exerted by myosin filaments29. Also, platelets are known to reorganize network architecture and to induce additional polymerization of fibrin1,30. However, the contribution of these mechanisms to the enhancement of network elasticity is unclear.

According to our measurements, platelets are two orders of magnitude stiffer than platelet-free clots and one order of magnitude stiffer than platelet-rich clots, indicating that platelets may additionally reinforce the mechanical properties of the clot directly, as in particle-filled elastomers31. Within this context, the high stiffness and adhesion of the platelets to the fibrin matrix may allow the platelet to directly bear some of the load, restrict local deformations of the fibrin matrix, and serve as a crosslinking centre within the fibrin gel (Supplementary Information). We speculate that direct enhancement of clot elasticity by platelets could be important during early phases of clot formation and contraction, when the fibrin gel is relatively sparse and most susceptible to deformation by physiological forces such as blood flow.

The AFM measurements on single platelets presented here reveal that platelets contract rapidly and generate high contraction and adhesive forces in a stiffness-dependent manner, which, we suggest, may lead to more uniform contraction of the clot as a whole (Fig. 4a). We note that these contraction results have direct implications for platelet aggregation (Supplementary Information) and indicate that mechanics, in addition to biological agonists such as ADP and epinephrine, may affect platelet aggregation. The combined effect of high platelet stiffness, attachment to multiple fibrin polymers, and high detachment forces contributes to the significant enhancement of the elasticity of clots by platelets (Fig. 4b). These two effects illustrate the complex mechanical properties of clots as a composite material, the properties of which are highly dependent on the specific interactions between platelets and the fibrin gel. These experiments improve our overall understanding of clot material properties in haemostasis and thrombosis, and this experimental system could potentially lead to new diagnostic assays and insight for cardiovascular disease and disorders of platelet function.

Figure 4
Proposed effects of platelets on clot retraction and mechanics

Methods

Experimental geometry and platelet capture in side-view AFM

Our experiments measured the contraction force applied by a single cell between opposing sides of the cell body and in a direction normal to the surface of attachment. Similarly, platelets embedded in a fibrin network must exert forces across their cell body to contract and pull fibrin fibres together, although typically with multiple points of contact22. In that regard, the configuration of our AFM measurements provides the simplest geometry possible within a fibrin scaffold, representing a platelet spanning two bundles of fibrin polymers and exerting contractile forces along the axis normal to the two fibres. This quasi-three-dimensional configuration positions a platelet for uniaxial contraction and therefore provides a convenient method to directly measure the maximum or total possible contraction force that a platelet embedded in a fibrin network can exert. In dense fibrin networks, the total force generated by actomyosin contraction would probably be distributed in multiple directions for platelets with multiple attachment points.

To capture platelets before they contacted a surface, we used a custom-built AFM with an integrated ‘side-view’ fluorescence microscope13. This system was important for our experiments, as platelets rapidly activate on contact with fibrinogen-coated surfaces32, and conventional bottom-view epifluorescence microscopy does not easily discriminate between platelets near the surface and platelets that have just come into contact with the surface but have not yet spread. The side-view imaging path was used to rapidly locate platelets that were near the surface but had not yet contacted, and then to initiate contact between the platelet and both the glass surface and AFM cantilever surface simultaneously (see Supplementary Video S4). When a diffusing platelet was positioned so that it contacted the surface and cantilever simultaneously, it contracted and pulled the flexible cantilever towards the surface (Fig. 1c). Side-view imaging provided visual confirmation of platelet contraction (Supplementary Video S1). The cantilever deflection during platelet contraction was detected with an optical lever, providing sub-nanometre-scale resolution of cantilever position and piconewton-scale resolution of cantilever force. AFM cantilevers behave like Hookean springs for small deflections, so that force is proportional to deflection.

Platelet activation in AFM experiments

Two signalling pathways mediate platelet contraction, both of which ultimately converge and result in actomyosin contraction. Binding of fibrin/fibrinogen to integrin αIIbβ3 (glycoprotein IIb/IIIa) receptors on the platelet surface initiates the main pathway, leading to calcium mobilization and activation of myosin light-chain kinase2. In addition, thrombin, a potent platelet activator produced during the clotting process, binds to specific receptors and initiates the rho kinase signalling pathway that inhibits myosin light-chain phosphatase, resulting in increased myosin activation15. In the results reported here, we used thrombin-activated platelets because thrombin is present during clot formation and retraction in vivo, and is used in in vitro bulk clot retraction studies. Control experiments confirmed that platelet contraction in our system was mediated by fibrinogen and integrin αIIbβ3, and was actomyosin and calcium-dependent, which is consistent with the present understanding of clot retraction (see Supplementary Information, Fig. S4). In addition, experiments with a fluorescent calcium indicator confirmed that platelet activation was maximum on contact with the cantilever and glass surfaces (Supplementary Fig. S5), although we cannot rule out some pre-activation on exposure to thrombin.

Elasticity and adhesion measurements

After platelet contraction was completed, we moved the surface away from the cantilever at a constant rate to determine the elasticity and extensibility of single platelets, as well as the adhesion strength between the platelet and the fibrinogen-coated surface or cantilever. As the surface was moved away, the attachment force between the platelet and the surface increased and the platelet elongated. We calculated the elasticity of the contracted platelet from the relationship between the measured platelet force per unit area (stress) and fractional change in platelet length (strain).

Supplementary Material

supplementary information

Acknowledgments

We thank S. Parekh, G. Venugopalan, G. Stephens, P. Andre, D. Phillips, X. Zhao and the Fletcher Lab for their advice and useful discussions. Financial support for this work was provided by an NSF GRFP for O.C., NIH grant K08-HL093360, a UCSF REAC award, and a Biomedical Research Fellowship from The Hartwell Foundation for W.A.L., and an NSF CAREER Award and NIH R01 grants to D.A.F.

Footnotes

Author contributions

W.A.L., O.C., A.C., K.D.W., J.H. and D.A.F. conceived and designed the experiments; W.A.L., O.C., T-D.L. and A.K. carried out the experiments; W.A.L., O.C. and D.A.F. analysed and interpreted the data; and W.A.L., O.C., D.A.F., A.C., K.D.W. and J.H. wrote the manuscript.

The authors declare no competing financial interests.

Supplementary information accompanies this paper on www.nature.com/naturematerials.

Reprints and permissions information is available online at http://npg.nature.com/reprintsandpermissions.

References

1. Niewiarowski S, Regoeczi E, Stewart GJ, Senyl AF, Mustard JF. Platelet interaction with polymerizing fibrin. J Clin Invest. 1972;51:685–699. [PMC free article] [PubMed]
2. Hartwig JH. In: Platelets. 2. Michelson AD, editor. Elsevier; 2007. pp. 75–97.
3. Ruggeri ZM. Platelet adhesion under flow. Microcirculation. 2009;16:58–83. [PMC free article] [PubMed]
4. Jen CJ, McIntire LV. The structural properties and contractile force of a clot. Cell Motil. 1982;2:445–455. [PubMed]
5. Storm C, Pastore JJ, MacKintosh FC, Lubensky TC, Janmey PA. Nonlinear elasticity in biological gels. Nature. 2005;435:191–194. [PubMed]
6. Weisel JW. Biophysics. Enigmas of blood clot elasticity. Science. 2008;320:456–457. [PubMed]
7. Collet JP, et al. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol. 2006;26:2567–2573. [PubMed]
8. Hvas AM, et al. Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A. J Thromb Haemost. 2007;5:2408–2414. [PubMed]
9. Carr ME. Jr Development of platelet contractile force as a research and clinical measure of platelet function. Cell Biochem Biophys. 2003;38:55–78. [PubMed]
10. Liu W, et al. Fibrin fibers have extraordinary extensibility and elasticity. Science. 2006;313:634. [PMC free article] [PubMed]
11. Brown AE, Litvinov RI, Discher DE, Purohit PK, Weisel JW. Multiscale mechanics of fibrin polymer: Gel stretching with protein unfolding and loss of water. Science. 2009;325:741–744. [PMC free article] [PubMed]
12. Weisel JW. The mechanical properties of fibrin for basic scientists and clinicians. Biophys Chem. 2004;112:267–276. [PubMed]
13. Chaudhuri O, Parekh SH, Lam WA, Fletcher DA. Combined atomic force microscopy and side-view optical imaging for mechanical studies of cells. Nature Methods. 2009;6:383–387. [PMC free article] [PubMed]
14. Rooney MM, Farrell DH, van Hemel BM, de Groot PG, Lord ST. The contribution of the three hypothesized integrin-binding sites in fibrinogen to platelet-mediated clot retraction. Blood. 1998;92:2374–2381. [PubMed]
15. Suzuki-Inoue K, et al. Involvement of Src kinases and PLCgamma2 in clot retraction. Thromb Res. 2007;120:251–258. [PMC free article] [PubMed]
16. Kiyoi T, et al. A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: Comparison with other mutations causing ligand-binding defects. Blood. 2003;101:3485–3491. [PubMed]
17. Ryan EA, Mockros LF, Weisel JW, Lorand L. Structural origins of fibrin clot rheology. Biophys J. 1999;77:2813–2826. [PubMed]
18. Choy JL, et al. Differential force microscope for long time-scale biophysical measurements. Rev Sci Instrum. 2007;78:043711. [PMC free article] [PubMed]
19. Mitrossilis D, et al. Single-cell response to stiffness exhibits muscle-like behavior. Proc Natl Acad Sci USA. 2009;106:18243–18248. [PubMed]
20. Allioux-Guerin M, et al. Spatiotemporal analysis of cell response to a rigidity gradient: A quantitative study using multiple optical tweezers. Biophys J. 2009;96:238–247. [PubMed]
21. Kajzar A, Cesa CM, Kirchgessner N, Hoffmann B, Merkel R. Toward physiological conditions for cell analyses: Forces of heart muscle cells suspended between elastic micropillars. Biophys J. 2008;94:1854–1866. [PubMed]
22. Cohen I, Gerrard JM, White JG. Ultrastructure of clots during isometric contraction. J Cell Biol. 1982;93:775–787. [PMC free article] [PubMed]
23. Satoh H, Delbridge LM, Blatter LA, Bers DM. Surface: Volume relationship in cardiac myocytes studied with confocal microscopy and membrane capacitance measurements: Species-dependence and developmental effects. Biophys J. 1996;70:1494–1504. [PubMed]
24. Finer JT, Simmons RM, Spudich JA. Single myosin molecule mechanics: Piconewton forces and nanometre steps. Nature. 1994;368:113–119. [PubMed]
25. Piazzesi G, et al. Skeletal muscle performance determined by modulation of number of myosin motors rather than motor force or stroke size. Cell. 2007;131:784–795. [PubMed]
26. Brown AE, Litvinov RI, Discher DE, Weisel JW. Forced unfolding of coiled-coils in fibrinogen by single-molecule AFM. Biophys J. 2007;92:L39–L41. [PubMed]
27. Lang T, et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg. 2009;108:751–758. [PubMed]
28. Zhang X, et al. Atomic force microscopy measurement of leukocyte-endothelial interaction. Am J Physiol Heart Circ Physiol. 2004;286:H359–H367. [PubMed]
29. Koenderink GH, et al. An active biopolymer network controlled by molecular motors. Proc Natl Acad Sci USA. 2009;106:15192–15197. [PubMed]
30. Leistikow EA. Platelet internalization in early thrombogenesis. Semin Thromb Hemost. 1996;22:289–294. [PubMed]
31. Bergstrom JS, Boyce M. C Mechanical behavior of particle filled elastomers. Rubber Chem Technol. 1999;72:633–656.
32. Bonnefoy A, Liu Q, Legrand C, Frojmovic MM. Efficiency of platelet adhesion to fibrinogen depends on both cell activation and flow. Biophys J. 2000;78:2834–2843. [PubMed]